FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY FEMORAL PROTHESIS

MDR report key: 3223693 · Received July 12, 2013

Report

Report Number
1818910-2013-21066
Event Type
Injury
Date Received
July 12, 2013
Date of Event
June 20, 2013
Report Date
June 20, 2013
Manufacturer
1818910 DEPUY ORTHOPAEDICS, INC.
Product Code
JDI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. PATIENT MEDICAL RECORDS AND X-RAYS WERE PROVIDED. REVIEW OF THE SUPPLIED INVESTIGATIONAL INPUTS CONFIRMED OSTEOLYSIS AND LOOSENING OF THE FEMORAL AND TIBIAL COMPONENT. REVIEW OF THE DEVICE HISTORY RECORDS AND/OR A COMPLAINT DATABASE SEARCH WAS NOT POSSIBLE AS THE PRODUCT AND LOT CODES REQUIRED WERE NOT PROVIDED. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS ABOUT THE ROOT CAUSE OF THE OSTEOLYSIS OR THE LOOSENED FEMORAL AND TIBIAL COMPONENT BASED ON THE PROVIDED INFORMATION. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS LOOSENING OF THE FEMORAL COMPONENT AND THE TIBIAL TRAY AT BOTH INTERFACES. THE TIBIAL TRAY HAD ALSO SUBSIDED. THE MANUFACTURER OF THE CEMENT USED AT THE TIME OF ORIGINAL IMPLANTATION IS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
323784 UNKNOWN DEPUY FEMORAL PROTHESIS FEMORAL PROTHESIS JDI 1818910 DEPUY ORTHOPAEDICS, INC. UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 68 YR Required Intervention